Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 12;24(1):1013.
doi: 10.1186/s12889-024-18203-8.

Estimated public health impact of concurrent mask mandate and vaccinate-or-test requirement in Illinois, October to December 2021

Affiliations

Estimated public health impact of concurrent mask mandate and vaccinate-or-test requirement in Illinois, October to December 2021

François M Castonguay et al. BMC Public Health. .

Abstract

Background: Facing a surge of COVID-19 cases in late August 2021, the U.S. state of Illinois re-enacted its COVID-19 mask mandate for the general public and issued a requirement for workers in certain professions to be vaccinated against COVID-19 or undergo weekly testing. The mask mandate required any individual, regardless of their vaccination status, to wear a well-fitting mask in an indoor setting.

Methods: We used Illinois Department of Public Health's COVID-19 confirmed case and vaccination data and investigated scenarios where masking and vaccination would have been reduced to mimic what would have happened had the mask mandate or vaccine requirement not been put in place. The study examined a range of potential reductions in masking and vaccination mimicking potential scenarios had the mask mandate or vaccine requirement not been enacted. We estimated COVID-19 cases and hospitalizations averted by changes in masking and vaccination during the period covering October 20 to December 20, 2021.

Results: We find that the announcement and implementation of a mask mandate are likely to correlate with a strong protective effect at reducing COVID-19 burden and the announcement of a vaccinate-or-test requirement among frontline professionals is likely to correlate with a more modest protective effect at reducing COVID-19 burden. In our most conservative scenario, we estimated that from the period of October 20 to December 20, 2021, the mask mandate likely prevented approximately 58,000 cases and 1,175 hospitalizations, while the vaccinate-or-test requirement may have prevented at most approximately 24,000 cases and 475 hospitalizations.

Conclusion: Our results indicate that mask mandates and vaccine-or-test requirements are vital in mitigating the burden of COVID-19 during surges of the virus.

Keywords: COVID-19; Cases and hospitalizations averted; Masks; Modeling; Vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Fitted epidemic curves of COVID-19 case counts showing the impact of the mask mandate Notes: Fitted epidemic curve of observed COVID-19 case counts, assuming a post-mandate mask effectiveness of 14.2%, and simulated epidemic curves assuming no mandate and continuation of pre-mandate mask effectiveness of either 7.2% or 11.2% (all three for the October 20 – December 20, 2021 period). The solid line is Illinois’s observed (fitted) cumulative COVID-19 case counts, and the broken lines are the simulated curves illustrating the cumulative total COVID-19 cases for the various scenarios that might have occurred if the mask mandate had not been enacted and mask efficacy was 20%. The differences between the solid and broken lines show the benefits of the mask mandate with greater divergence between the solid and broken lines indicating a greater impact. All results assume that the effects of nonpharmaceutical interventions —including masks—were constant over the two months shown
Fig. 2
Fig. 2
Fitted epidemic curves of COVID-19 case counts showing the impact of the vaccinate-or-test requirement Notes: Fitted epidemic curve of observed COVID-19 case counts and of two assumed increases in vaccination coverage attributable to the announcement of the vaccinate-or-test requirement (for October 20 – December 20, 2021). These represent approximately 51,580 and 103,160 individuals vaccinated because of the vaccinate-or-test requirement. The solid line is Illinois’s observed cumulative COVID-19 case counts, and the dashed and dotted lines are the simulated curves illustrating the cumulative total cases for scenarios where there would have been a lower vaccine uptake without the vaccinate-or-test requirement. The differences between the solid and dashed or dotted lines show the number of cases averted by the vaccinate-or-test requirement. All results assume that the effects of other nonpharmaceutical interventions (NPIs) were constant over the two months analyzed

References

    1. Abaluck J, Kwong LH, Styczynski A, Haque A, Kabir MA, Bates-Jefferys E, Crawford E, Benjamin-Chung J, Raihan S, Rahman S , et al. Impact of community masking on COVID-19: a cluster-randomized trial in Bangladesh, Science. 2022;375(6577):eabi9069. doi: 10.1126/science.abi9069. - DOI - PMC - PubMed
    1. Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, Todsen T, Norsk JB, Pries-Heje MM, Vissing CR, Nielsen PB, Winslow UC , et al. Effectiveness of adding a mask recommendation to other public health measures to prevent SARS-CoV-2 infection in Danish mask wearers: a randomized controlled trial. Annals Internal Med. 2021;174(3):335–343. doi: 10.7326/M20-6817. - DOI - PMC - PubMed
    1. Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, Van Der Westhuizen HM, Von Delft A, Price A, Fridman L , Tang LH, et al. An evidence review of face masks against COVID-19. Proc Nat Acad Sci. 2021;118(4): e2014564118. doi: 10.1073/pnas.2014564118. - DOI - PMC - PubMed
    1. Eikenberry SE, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y, Kostelich E, Gumel AB. To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infectious disease modelling. 2020;5:293–308. doi: 10.1016/j.idm.2020.04.001. - DOI - PMC - PubMed
    1. Mohammed I, Nauman A, Paul P, Ganesan S, Chen KH , Jalil SMS, Jaouni SH, Kawas H, Khan WA, Vattoth AL, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: A systematic review. Hum Vaccin immunother. 2022;18(1):2027160. doi: 10.1080/21645515.2022.2027160. - DOI - PMC - PubMed